Jennifer J. Knox - Publications, H-index & Citations

Jennifer J. Knox

university health network

80H指数

829论文数

3.5W被引数

收录论文 153

发表时间

Beyond the breakthrough for RAS-driven cancers RAS驱动型癌症的突破性进展

Nature Medicine

IF50

2026-09-15

PREAI

Rich C. King; Erica S. Tsang; Jennifer J. Knox

LIVER-R study protocol: a global real-world study of durvalumab-based regimens in patients with hepatobiliary cancers LIVER-R研究方案：一项关于 durvalumab为基础方案在肝胆肿瘤患者中的全球真实世界研究

Future Oncology

IF2.6

2025-11-24

OAAI

Masafumi Ikeda; Marcus-Alexander Wörns; Mehmet Akce; Chiun Hsu; Niall C. Tebbutt; Andrea Casadei-Gardini; Janvi Sah; Mufiza Farid-Kapadia; Heide A. Stirnadel-Farrant; Michael J. Paskow; Boris Baur; Giovanni Melillo; James Schmidt; Anna Daktera; Jennifer J. Knox

Surrogate Endpoints for Overall Survival in Advanced Hepatocelluar Carcinoma in the Era of Immunotherapy: A Trial Level Meta-Analysis 免疫治疗时代晚期肝细胞癌总生存期的替代终点：一项试验水平Meta分析

LIVER CANCER

IF9.1

2025-09-01

PREAI

Saleh, Yacob; Baskurt, Zeynep; Farooq, Abdul Rehman; Goodwin, Rachel; Knox, Jennifer; O'kane, Grainne; Chen, Eric Xueyu

Evolutionary dynamics of recurrent hepatocellular carcinoma under divergent immune selection pressures 复发性肝细胞癌在分化免疫选择压力下的进化动力学

Frontiers in Oncology

IF3.3

2025-08-05

OAAI

Ankur Chakravarthy‡; Elisa Pasini‡; Xun Zhao; Jeffrey To; Shu Yi (Roxana) Shen; Sandra Fischer; Anand Ghanekar‡; Arndt Vogel‡; Robert C. Grant‡; Jennifer Knox; Gonzalo Sapisochin‡; Gregory J. Gores‡; Daniel De Carvalho†; Mamatha Bhat†‡

Role of immune checkpoint inhibitor combinations in resectable and unresectable, embolization-eligible hepatocellular carcinoma 免疫检查点抑制剂联合疗法在可切除和不可切除、栓塞治疗适应的肝细胞癌中的角色

Therapeutic Advances in Medical Oncology

IF4.2

2025-07-24

OAAI

Brandon M. Meyers; Howard J. Lim; Mayur Brahmania; Dave M. Liu; Vincent C. Tam; Deanna McLeod; Ravi Ramjeesingh; Jennifer J. Knox; Arndt Vogel

Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinoma 多组学全基因组表征转移性胰腺导管腺癌的拷贝数景观

iScience

IF4.1

2025-07-22

OAAI

James T. Topham; Joanna M. Karasinska; Andrew Metcalfe; Hassan A. Ali; Steve E. Kalloger; Maya Kevorkova; Emma Titmuss; Gian Luca Negri; Sandra E. Spencer; Gun Ho Jang; Grainne M. O’Kane; Richard A. Moore; Andrew J. Mungall; Jonathan M. Loree; Faiyaz Notta; Julie M. Wilson; Oliver F. Bathe; Patricia A. Tang; Rachel Goodwin; Gregg B. Morin; Jennifer J. Knox; Steven Gallinger; Janessa Laskin; Marco A. Marra; Steven J.M. Jones; Daniel J. Renouf; David F. Schaeffer

Minimally invasive determination of pancreatic ductal adenocarcinoma (PDAC) subtype by means of circulating cell-free RNA 通过循环无细胞RNA微创确定胰腺导管腺癌 (PDAC) 亚型

MOLECULAR ONCOLOGY

IF4.5

2024-10-31

OAAI

Metzenmacher, Martin; Zaun, Gregor; Trajkovic-Arsic, Marija; Cheung, Phyllis; Reissig, Timm M.; Schuermann, Hendrik; von Neuhoff, Nils; O'Kane, Grainne; Ramotar, Stephanie; Dodd, Anna; Gallinger, Steven; Muckenhuber, Alexander; Knox, Jennifer J.; Kunzmann, Volker; Horn, Peter A.; Hoheisel, Joerg D.; Siveke, Jens T.; Lueong, Smiths S.

Genomic and transcriptomic characterization of pancreatic cancer patients on the PASS-01 trial

CANCER RESEARCH

IF16.6

2024-09-15

PREAI

O'Kane, Grainne M.; Jang, Gunho; Pugh, Trevor J.; Wilson, Julie; Ramotar, Stephanie; King, Daniel A.; Laheru, Dan; Yu, Ken H.; Perez, Kimberly J.; Habowski, Amber; Tsang, Erica S.; Grant, Robert C.; Aguirre, Andrew J.; Jang, Raymond W-J; Devoe, Craig E.; O'Reilly, Eileen M.; Dodd, Anna; Wolpin, Brian M.; Ye, Xiang Y.; Jaffee, Elizabeth M.; Tuveson, David; Gallinger, Steven; Knox, Jennifer J.; Notta, Faiyaz

Patient-derived organoids and precision medicine: Insights from the PASS-01 clinical trial in PDAC

CANCER RESEARCH

IF16.6

2024-09-15

PREAI

Habowski, Amber N.; Plenker, Dennis; Patel, Hardik; Tsang, Caitlin; St Surin, Luce; Kouassi, Fatim; Budagavi, Deepthi; O'Kane, Grainne M.; Ramotar, Stephanie; Yu, Kenneth H.; Notta, Faiyaz; Aguirre, Andrew; Wolpin, Brian; Laheru, Dan; King, Daniel A.; Jaffee, Elizabeth M.; Knox, Jennifer J.; Tuveson, David A.

A Case of First-line Atezolizumab Plus Bevacizumab Use in Recurrence of Combined Hepatocellular Cholangiocarcinoma After Surgical Resection

clinical and experimental pediatrics

IF3.2

2024-09-01

PREAI

Moffat, Gordon T.; Duan, Kai; Knog, Jennifer J.

NeoPancONE: Feasibility of completing a neoadjuvant multicentre phase II study in resectable pancreatic ductal adenocarcinoma (r-PDAC), treated with modified FOLFIRINOX (mFFX)

ANNALS OF ONCOLOGY

IF65.4

2024-06-01

PREAI

McLaughlin, R. A.; Coyne, Z.; Jonker, D.; Karanicolas, P.; Hakim, S.; Welch, S.; Renouf, D. J.; Bertens, K.; Moulton, C-A.; Raphael, M.; Jayaraman, S.; Moore, M.; Elimova, E.; Coburn, N.; Abou-Khalil, J.; Khalili, K.; Fischer, S. E.; Dodd, A.; Gallinger, S.; Knox, J. J.

Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040 Nivolumab联合ipilimumab治疗先前接受索拉非尼治疗的晚期肝细胞癌患者: CheckMate 040的5年结果

ANNALS OF ONCOLOGY

IF65.4

2024-06-01

OAAI

Melero, I.; Yau, T.; Kang, Y. -K.; Kim, T. -Y.; Santoro, A.; Sangro, B.; Kudo, M.; Hou, M. -M.; Matilla, A.; Tovoli, F.; Knox, J.; He, A. R.; El-Rayes, B.; Acosta-Rivera, M.; Lim, H. Y.; Soleymani, S.; Yao, J.; Neely, J.; Tschaika, M.; Hsu, C.; El-Khoueiry, A. B.

A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinoma

JHEP REPORTS

IF7.5

2024-04-01

OAAI

Santoro, Armando; Assenat, Eric; Yau, Thomas; Delord, Jean -Pierre; Maur, Michela; Knox, Jennifer; Cattan, Stephane; Lee, Kyung-Hun; Del Conte, Gianluca; Springfeld, Christoph; Leo, Elisa; Xyrafas, Alexandros; Fairchild, Lauren; Mardjuadi, Feby; Chan, Stephen L.

Characterization of Tumor Responses in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in the Phase 3 Randomized Trial: REFLECT

LIVER CANCER

IF9.1

2024-02-26

OAAI

Finn, Richard S.; Qin, Shukui; Piscaglia, Fabio; Evans, Thomas R. Jeffry; Knox, Jennifer J.; Lopez Lopez, Carlos; Ramji, Zahra; Ren, Min; Mody, Kalgi; Vogel, Arndt; Kudo, Masatoshi

Circulating Oncometabolite 2-hydroxyglutarate as a Potential Biomarker for Isocitrate Dehydrogenase (IDH1/2) Mutant Cholangiocarcinoma 循环肿瘤代谢物2-羟基戊二酸作为异柠檬酸脱氢酶 (IDH1/2) 突变型胆管癌的潜在生物标志物

MOLECULAR CANCER THERAPEUTICS

IF5.5

2023-11-28

OAAI

Lee, Cha Len; O'Kane, Grainne M.; Mason, Warren P.; Zhang, Wen-Jiang; Spiliopoulou, Pavlina; Hansen, Aaron R.; Grant, Robert C.; Knox, Jennifer J.; Stockley, Tracy L.; Zadeh, Gelareh; Chen, Eric X.

First impressions: A prospective evaluation of patient comprehension and satisfaction in the communication of diagnosis, treatment, and prognosis following the initial medical oncology consultation

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

PREAI

Bach, Y.; Panov, E. D.; Espin-Garcia, O.; Chen, E.; Krzyzanowska, M. K.; O'Kane, G. M.; Moore, M.; Prince, R.; Knox, J.; Grant, R.; Ma, L.; Allen, M.; Eng, L.; Megid, T.; Jang, R. W-J.; Elimova, E.

BRAFΔß3-αC in-frame deletion mutants differ in their dimerization propensity, HSP90 dependence, and druggability

SCIENCE ADVANCES

IF12.5

2023-09-01

OAAI

Lauinger, Manuel; Christen, Daniel; Klar, Rhena F. U.; Roubaty, Carole; Heilig, Christoph E.; Stumpe, Michael; Knox, Jennifer J.; Radulovich, Nikolina; Tamblyn, Laura; Xie, Irene Y.; Horak, Peter; Forschner, Andrea; Bitzer, Michael; Wittel, Uwe A.; Boerries, Melanie; Ball, Claudia R.; Heining, Christoph; Glimm, Hanno; Froehlich, Martina; Huebschmann, Daniel; Gallinger, Steven; Fritsch, Ralph; Froehling, Stefan; O'Kane, Grainne M.; Dengjel, Joern; Brummer, Tilman

A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors

ENDOCRINE-RELATED CANCER

IF4.6

2023-08-21

OAAI

Abuzakhm, Sonia M.; Sukrithan, Vineeth; Fruth, Briant; Qin, Rui; Strosberg, Jonathan; Hobday, Timothy J.; Semrad, Thomas; Reidy-Lagunes, Diane; Kindler, Hedy Lee; Kim, George P.; Knox, Jennifer J.; Kaubisch, Andreas; Villalona-Calero, Miguel; Chen, Helen; Erlichman, Charles; Shah, Manisha H.

The evolution of immune checkpoint inhibitor combinations in advanced hepatocellular carcinoma-A systematic review 晚期肝细胞癌中免疫检查点抑制剂组合的演变-系统综述

CANCER TREATMENT REVIEWS

IF10.5

2023-07-01

PREAI

Meyers, Brandon M.; Knox, Jennifer J.; Liu, David M.; McLeod, Deanna; Ramjeesingh, Ravi; Tam, Vincent C.; Lim, Howard J.

Phase III study of NUC-1031+cisplatin vs gemcitabine plus cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)

ANNALS OF ONCOLOGY

IF65.4

2023-06-01

OAAI

Knox, J.; Bazin, I.; Oh, D.; Zubkov, O.; Breder, V.; Bai, L.; Christie, A.; McNamara, M.; Goyal, L.; Cosgrove, D.; Springfeld, C.; Sjoquist, K.; Park, J.; Verdaguer, H.; Braconi, C.; Ross, P.; de Gramont, A.; Shroff, R.; Zalcberg, J.; Palmer, D.; Valle, J.

研究方向